OncoNano Medicine
PrivateLast Round
Series B
Extension
Jun 2, 2025
Est. Valuation
$60M
Total Funding Raised
$216.27M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
OncoNano Medicine is a biotechnology company that develops pH-activated compounds designed to detect and treat diseased tissue, with a focus on enhancing cancer treatment during surgery and post-operative evaluation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoNano Medicine Comparables
Compare OncoNano Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| pHLIP, Inc. | 87% | |
| Cybrexa Therapeutics | 84% | |
| Xilio Therapeutics | 74% |
OncoNano Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jun 2, 2025 | ||||
| Series B | Oct 25, 2021 | ||||
| Series B | Jun 17, 2021 | ||||
| Grant | Aug 20, 2020 | ||||
| Grant | Aug 27, 2019 | ||||
Series A | Jul 9, 2019 |
OncoNano Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advantech Capital | Series B |
| Salem Partners | Series B Extension, Series A |
| Cancer Prevention and Research Institute of Texas | Grant, Series B |
| Cancer Prevention and Research Institute of Texas (CPRIT) | Grant, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 96% MoM, reaching 3.1K.
- Apr 17, 2026
Presenting preclinical data at the AACR Annual Meeting 2026.
OncoNano Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OncoNano Medicine's valuation, stock price, and market status.
Is OncoNano a public or private company?
OncoNano is a private company.
What is the current stock price of OncoNano?
OncoNano is a private company with no public stock price. No recent secondary market data is available.
How much is OncoNano worth (valuation)?
OncoNano's valuation is estimated at $60.0M based on funding round data.
Can I buy OncoNano stock?
OncoNano shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OncoNano's last funding round?
OncoNano's most recent funding round was Series B Extension on June 2, 2025.
Who are the main investors in OncoNano?
Key investors in OncoNano include Advantech Capital, Salem Partners, Cancer Prevention and Research Institute of Texas.
Will OncoNano IPO soon?
No public IPO plans have been announced for OncoNano.
How can I track OncoNano secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoNano's secondary market activity and sign up for updates.